相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Genomic Landscape and Pharmacogenomic Interactions of Clock Genes in Cancer Chronotherapy
Youqiong Ye et al.
CELL SYSTEMS (2018)
Enhancing circadian clock function in cancer cells inhibits tumor growth
Silke Kiessling et al.
BMC BIOLOGY (2017)
Circadian disruption and biomarkers of tumor progression in breast cancer patients awaiting surgery
E. Cash et al.
BRAIN BEHAVIOR AND IMMUNITY (2015)
Histone methylation modifiers in cellular signaling pathways
Hunain Alam et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2015)
FDA Approval: Belinostat for the Treatment of Patients with Relapsed or Refractory Peripheral T-cell Lymphoma
Hyon-Zu Lee et al.
CLINICAL CANCER RESEARCH (2015)
Chronically Alternating Light Cycles Increase Breast Cancer Risk in Mice
Kirsten C. G. Van Dycke et al.
CURRENT BIOLOGY (2015)
Circadian gene hClock enhances proliferation and inhibits apoptosis of human colorectal carcinoma cells in vitro and in vivo
Yaping Wang et al.
MOLECULAR MEDICINE REPORTS (2015)
Daily Variation in Global and Local DNA Methylation in Mouse Livers
Lin Xia et al.
PLOS ONE (2015)
Circadian gene variants in cancer
Nicole M. Kettner et al.
ANNALS OF MEDICINE (2014)
Sensing core histone phosphorylation - A matter of perfect timing
Anna Sawicka et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2014)
The circadian clock and cell cycle: interconnected biological circuits
Selma Masri et al.
CURRENT OPINION IN CELL BIOLOGY (2013)
Circadian Gene Expression and Clinicopathologic Correlates in Pancreatic Cancer
Daniel Relles et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2013)
NONO couples the circadian clock to the cell cycle
Elzbieta Kowalska et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Cyclin-dependent kinase inhibitor p20 controls circadian cell-cycle timing
Ricardo Laranjeiro et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Functional polymorphisms of circadian positive feedback regulation genes and clinical outcome of Chinese patients with resected colorectal cancer
Feng Zhou et al.
CANCER (2012)
Regulation of Circadian Behavioral Output via a MicroRNA-JAK/STAT Circuit
Wenyu Luo et al.
CELL (2012)
Connecting Threads: Epigenetics and Metabolism
Sayako Katada et al.
CELL (2012)
The circadian clock gene BMAL1 is a novel therapeutic target for malignant pleural mesothelioma
Momen Elshazley et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Light Acts on the Zebrafish Circadian Clock to Suppress Rhythmic Mitosis and Cell Proliferation
T. Katherine Tamai et al.
JOURNAL OF BIOLOGICAL RHYTHMS (2012)
Trials with 'epigenetic' drugs: An update
Angela Nebbioso et al.
MOLECULAR ONCOLOGY (2012)
Circadian clock protein cryptochrome regulates the expression of proinflammatory cytokines
Rajesh Narasimamurthy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
The role of polymorphisms in circadian pathway genes in breast tumorigenesis
Hongji Dai et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Altered Expression of Circadian Clock Genes in Human Chronic Myeloid Leukemia
Ming-Yu Yang et al.
JOURNAL OF BIOLOGICAL RHYTHMS (2011)
Circadian regulation of molecular, dietary, and metabolic signaling mechanisms of human breast cancer growth by the nocturnal melatonin signal and the consequences of its disruption by light at night
David E. Blask et al.
JOURNAL OF PINEAL RESEARCH (2011)
A Molecular Mechanism for Circadian Clock Negative Feedback
Hao A. Duong et al.
SCIENCE (2011)
Circadian Timing in Cancer Treatments
Francis Levi et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2010)
Deregulated Expression of the Per1 and Per2 in Human Gliomas
He-chun Xia et al.
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES (2010)
CLOCK in Breast Tumorigenesis: Genetic, Epigenetic, and Transcriptional Profiling Analyses
Aaron E. Hoffman et al.
CANCER RESEARCH (2010)
Elevated ATPase Activity of KaiC Applies a Circadian Checkpoint on Cell Division in Synechococcus elongatus
Guogang Dong et al.
CELL (2010)
Romidepsin: a new therapy for cutaneous T-cell lymphoma and a potential therapy for solid tumors
Cliona Grant et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2010)
Coactivation of the CLOCK-BMAL1 complex by CBP mediates resetting of the circadian clock
Yool Lee et al.
JOURNAL OF CELL SCIENCE (2010)
Plasticity and specificity of the circadian epigenome
Selma Masri et al.
NATURE NEUROSCIENCE (2010)
The histone methyltransferase MLL1 permits the oscillation of circadian gene expression
Sayako Katada et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2010)
Disrupting Circadian Homeostasis of Sympathetic Signaling Promotes Tumor Development in Mice
Susie Lee et al.
PLOS ONE (2010)
Per2 Inhibits K562 Leukemia Cell Growth In Vitro and In Vivo Through Cell Cycle Arrest and Apoptosis Induction
Cheng-ming Sun et al.
PATHOLOGY & ONCOLOGY RESEARCH (2010)
Covalent histone modifications - miswritten, misinterpreted and mis-erased in human cancers
Ping Chi et al.
NATURE REVIEWS CANCER (2010)
Gene expression-signature of belinostat in cell lines is specific for histone deacetylase inhibitor treatment, with a corresponding signature in xenografts
Anne Monks et al.
ANTI-CANCER DRUGS (2009)
Down regulation of circadian clock gene Period 2 accelerates breast cancer growth by altering its daily growth rhythm
Xiaoming Yang et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Testing the Circadian Gene Hypothesis in Prostate Cancer: A Population-Based Case-Control Study
Yong Zhu et al.
CANCER RESEARCH (2009)
Epigenetic Inactivation of the Circadian Clock Gene BMAL1 in Hematologic Malignancies
Hiroaki Taniguchi et al.
CANCER RESEARCH (2009)
A Role for the Clock Gene Per1 in Prostate Cancer
Qi Cao et al.
CANCER RESEARCH (2009)
The Emerging Therapeutic Potential of Histone Methyltransferase and Demethylase Inhibitors
Astrid Spannhoff et al.
CHEMMEDCHEM (2009)
Combined PER2 and CRY1 expression predicts outcome in chronic lymphocytic leukemia
Lewin Eisele et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2009)
Cryptochrome-1 expression: a new prognostic marker in B-cell chronic lymphocytic leukemia
Eloisa Jantus Lewintre et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
A Large Scale shRNA Barcode Screen Identifies the Circadian Clock Component ARNTL as Putative Regulator of the p53 Tumor Suppressor Pathway
Jasper Mullenders et al.
PLOS ONE (2009)
Genome-Wide Profile of Pleural Mesothelioma versus Parietal and Visceral Pleura: The Emerging Gene Portrait of the Mesothelioma Phenotype
Oluf Dimitri Roe et al.
PLOS ONE (2009)
Circadian Clock Feedback Cycle Through NAMPT-Mediated NAD(+) Biosynthesis
Kathryn Moynihan Ramsey et al.
SCIENCE (2009)
Overexpression of Aurora B is associated with poor prognosis in epithelial ovarian cancer patients
Yi-Jen Chen et al.
VIRCHOWS ARCHIV (2009)
Disturbance of circadian gene expression in breast cancer
Shou-Jen Kuo et al.
VIRCHOWS ARCHIV (2009)
Clinicopathological significance of circadian rhythm-related gene expression levels in patients with epithelial ovarian cancer
Hideki Tokunaga et al.
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA (2008)
Aurora kinase B is a predictive factor for the aggressive recurrence of hepatocelluar carcinoma after curative hepatectomy
S. Tanaka et al.
BRITISH JOURNAL OF SURGERY (2008)
The NAD+-dependent deacetylase SIRT1 modulates CLOCK-mediated chromatin remodeling and circadian control
Yasukazu Nakahata et al.
CELL (2008)
Period 2 Mutation Accelerates ApcMin/+ Tumorigenesis
Patricia A. Wood et al.
MOLECULAR CANCER RESEARCH (2008)
Nuclear receptor corepressor and histone deacetylase 3 govern circadian metabolic physiology
Theresa Alenghat et al.
NATURE (2008)
The circadian clock component BMAL1 is a critical regulator of p21WAF1/CIP1 expression and hepatocyte proliferation
Aline Grechez-Cassiau et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Histone deacetylases: target enzymes for cancer therapy
Denis Mottet et al.
CLINICAL & EXPERIMENTAL METASTASIS (2008)
CLOCK-mediated acetylation of BMAL1 controls circadian function
Jun Hirayama et al.
NATURE (2007)
The role of azacitidine in the treatment of myelodysplastic syndromes
Haifaa Abdulhaq et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2007)
Organismal differences in post-translational modifications in histones H3 and H4
Benjamin A. Garcia et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Epigenetic silencing of the candidate tumor suppressor gene Per1 in non-small cell lung cancer
Sigal Gery et al.
CLINICAL CANCER RESEARCH (2007)
Ala394Thr polymorphism in the clock gene NPAS2: A circadian modifier for the risk of non-Hodgkin's lymphoma
Yong Zhu et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Downregulation of circadian clock genes in chronic myeloid leukemia:: Alternative methylation pattern of hPER3
Ming-Yu Yang et al.
CANCER SCIENCE (2006)
Molecular overlap of fly circadian rhythms and human pancreatic cancer
Kay L. Pogue-Geile et al.
CANCER LETTERS (2006)
Promoter methylation in circadian genes of endometrial cancers detected by methylation-specific PCR
Mu-Chin Shih et al.
MOLECULAR CARCINOGENESIS (2006)
The polycomb group protein EZH2 is required for mammalian circadian clock function
Jean-Pierre Etchegaray et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Insulin-like growth factor-I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk in The Nurses Health Study II
Eva S. Schemhammer et al.
ENDOCRINE-RELATED CANCER (2006)
Circadian regulator CLOCK is a histone acetyltransferase
Masao Doi et al.
CELL (2006)
The circadian gene Per1 plays an important role in cell growth and DNA damage control in human cancer cells
S Gery et al.
MOLECULAR CELL (2006)
Tumor suppression by the mammalian Period genes
CC Lee
CANCER CAUSES & CONTROL (2006)
Disruption of circadian coordination and malignant growth
E Filipski et al.
CANCER CAUSES & CONTROL (2006)
Rhythmic CLOCK-BMAL1 binding to multiple E-box motifs drives circadian Dbp transcription and chromatin transitions
JRA Ripperger et al.
NATURE GENETICS (2006)
Genomic DNA methylation: the mark and its mediators
RJ Klose et al.
TRENDS IN BIOCHEMICAL SCIENCES (2006)
Common pathways in circadian and cell cycle clocks: Light-dependent activation of Fos/AP-1 in zebrafish controls CRY-1a and WEE-1
J Hirayama et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Deregulated expression of the PER1, PER2 and PER3 genes in breast cancers
ST Chen et al.
CARCINOGENESIS (2005)
Abnormal expression of Period 1 (PER1) in endometrial carcinoma
KT Yeh et al.
JOURNAL OF PATHOLOGY (2005)
Coupling of human circadian and cell cycles by the timeless protein
K Ünsal-Kaçmaz et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer
MF Fraga et al.
NATURE GENETICS (2005)
Histone acetyltransferase-dependent chromatin remodeling and the vascular clock
AM Curtis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Circadian and light-induced transcription of clock gene Per1 depends on histone acetylation and deacetylation
Y Naruse et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Circadian variations of rectal cell proliferation in patients affected by advanced colorectal cancer
G Brandi et al.
CANCER LETTERS (2004)
Control mechanism of the circadian clock for timing of cell division in vivo
T Matsuo et al.
SCIENCE (2003)
Cancer chronotherapy: Principles, applications, and perspectives
B Vincenzi et al.
CANCER (2003)
Rhythmic histone acetylation underlies transcription in the mammalian circadian clock
JP Etchegaray et al.
NATURE (2003)
Distinct mechanisms determine transposon inheritance and methylation via small interfering RNA and histone modification
Z Lippman et al.
PLOS BIOLOGY (2003)
The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo
LN Fu et al.
CELL (2002)
Coordination of circadian timing in mammals
SM Reppert et al.
NATURE (2002)
Coordinated transcription of key pathways in the mouse by the circadian clock
S Panda et al.
CELL (2002)
Night shift work, light at night, and risk of breast cancer
S Davis et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2001)
Rotating night shifts and risk of breast cancer in women participating in the nurses' health study
ES Schernhammer et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2001)
Transcription regulation by histone methylation: interplay between different covalent modifications of the core histone tails
Y Zhang et al.
GENES & DEVELOPMENT (2001)
Sodium butyrate induces transcription from the Gαi2 gene promoter through multiple Sp1 sites in the promoter and by activating the MEK-ERK signal transduction pathway
JQ Yang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Risk of breast cancer in female flight attendants:: a population-based study (Iceland)
V Rafnsson et al.
CANCER CAUSES & CONTROL (2001)
Regulation of G1 cyclin dependent kinases in the mammalian cell cycle
SV Ekholm et al.
CURRENT OPINION IN CELL BIOLOGY (2000)
Light induces chromatin modification in cells of the mammalian circadian clock
C Crosio et al.
NATURE NEUROSCIENCE (2000)
Deacetylation of p53 modulates its effect on cell growth and apoptosis
JY Luo et al.
NATURE (2000)
Butyrate and trichostatin A effects on the proliferation/differentiation of human intestinal epithelial cells:: induction of cyclin D3 and p21 expression
S Siavoshian et al.
GUT (2000)
Aberrant CpG-island methylation has non-random and tumour-type-specific patterns
JF Costello et al.
NATURE GENETICS (2000)
p300 collaborates with Sp1 and Sp3 in p21waf1/cip1 promoter activation induced by histone deacetylase inhibitor
HY Xiao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Transactivation mechanisms of mouse clock transcription factors, mClock and mArnt3
S Takahata et al.
GENES TO CELLS (2000)
分享论文
